Germ line mutations associated with breast cancer susceptibility (Q34175539)

31 July 2017

1 reference

title

Germ line mutations associated with breast cancer susceptibility (English)

1 reference

31 July 2017

Iau PT

1

1 reference

PubMed ID

11239752

31 July 2017

Macmillan RD

series ordinal

2

1 reference

PubMed ID

11239752

31 July 2017

Blamey RW

series ordinal

3

1 reference

31 July 2017

1 February 2001

1 reference

European Journal of Cancer

31 July 2017

1 reference

31 July 2017

37

1 reference

31 July 2017

3

1 reference

31 July 2017

300-321

1 reference

Characteristics of familial breast cancer in sweden: Absence of relation to age and unilateral versus bilateral disease

31 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Family history of breast cancer as a risk indicator for the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Some characteristics of familial breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Genetic study of breast cancer: identification of a high risk group

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Breast cancer in families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Tumor Variation in Families With Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Genetic epidemiology of breast cancer: segregation analysis of 200 Danish pedigrees.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Linkage of early-onset familial breast cancer to chromosome 17q21

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Familial breast-ovarian cancer locus on chromosome 17q12-q23

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Identification of the breast cancer susceptibility gene BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Frequency and carrier risk associated with common BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Penetrances of BRCA1 1675delA and 1135insA with respect to breast cancer and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

BRCA1 and BRCA2 testing: weighing the demand against the benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

BRCA1 and BRCA2: penetrating the clinical arena.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

The rapid detection of unknown mutations in nucleic acids.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Detection of polymorphisms of human DNA by gel electrophoresis as single-strand conformation polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Rapid detection of BRCA1 mutations by the protein truncation test

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Strand-separating conformational polymorphism analysis: efficacy of detection of point mutations in the human ornithine delta-aminotransferase gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Detecting single base substitutions as heteroduplex polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Protein truncation test (PTT) for rapid detection of translation-terminating mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

A Collaborative Survey of 80 Mutations in the BRCA1 Breast and Ovarian Cancer Susceptibility Gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Mutations of the APC (adenomatous polyposis coli) gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Molecular diagnosis of familial adenomatous polyposis.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Common origins of BRCA1 mutations in Canadian breast and ovarian cancer families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Mutation analysis of the BRCA1 gene in 23 families with cases of cancer of the breast, ovary, and multiple other sites

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

BRCA1 sequence analysis in women at high risk for susceptibility mutations. Risk factor analysis and implications for genetic testing.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

BRCA1 genomic deletions are major founder mutations in Dutch breast cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Sequence analysis of BRCA1 and BRCA2: correlation of mutations with family history and ovarian cancer risk

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Recurrent BRCA2 6174delT mutations in Ashkenazi Jewish women affected by breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

The carrier frequency of the BRCA2 6174delT mutation among Ashkenazi Jewish individuals is approximately 1%

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Ashkenazi Jewish population frequencies for common mutations in BRCA1 and BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Founder BRCA1 and BRCA2 mutations in French Canadian ovarian cancer cases unselected for family history

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Founder mutations in the BRCA1 gene in Polish families with breast-ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Evidence of a founder BRCA1 mutation in Scotland

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Colorectal cancer in hereditary breast cancer kindreds

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Absence of 185delAG mutation of the BRCA1 gene and 6174delT mutation of the BRCA2 gene in Ashkenazi Jewish men with prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Risk of prostate, ovarian, and endometrial cancer among relatives of women with breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Mutation analysis of the BRCA2 gene in 49 site-specific breast cancer families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Cancer risks in BRCA2 mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

BRCA2 is inactivated late in the development of pancreatic intraepithelial neoplasia: evidence and implications

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Common mutations in BRCA1 and BRCA2 do not contribute to early prostate cancer in Jewish men.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

No evidence for a role of BRCA1 or BRCA2 mutations in Ashkenazi Jewish families with hereditary prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Confirmation of BRCA1 by analysis of germline mutations linked to breast and ovarian cancer in ten families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Low proportion of BRCA1 and BRCA2 mutations in Finnish breast cancer families: evidence for additional susceptibility genes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Germline mutations of the BRCA1 gene in breast and ovarian cancer families provide evidence for a genotype–phenotype correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Variation of risks of breast and ovarian cancer associated with different germline mutations of the BRCA2 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Haplotype and phenotype analysis of nine recurrent BRCA2 mutations in 111 families: results of an international study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

BRCA1 mutations in primary breast and ovarian carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

BRCA2 mutations in primary breast and ovarian cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Histoprognostic grade in BRCA1-associated breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Hereditary breast cancer: pathobiology, prognosis, and BRCA1 and BRCA2 gene linkage

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Influence of BRCA1 mutations on nuclear grade and estrogen receptor status of breast carcinoma in Ashkenazi Jewish women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

The histologic phenotypes of breast carcinoma occurring before age 40 years in women with and without BRCA1 or BRCA2 germline mutations: a population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Intraductal component and BRCA1-associated breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

In-situ breast cancer and BRCA1

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

BRCA2 hereditary breast cancer pathophenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Inherited BRCA2 mutation associated with high grade breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Tumour biological features of BRCA1-induced breast and ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Survival and tumour characteristics of breast-cancer patients with germline mutations of BRCA1.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Hormone status of in-situ cancer in BRCA1 and BRCA2 mutation carriers.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Novel indications for BRCA1 screening using individual clinical and morphological features

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Survival in hereditary breast cancer associated with germline mutations of BRCA2.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Clinicopathologic analysis of BRCA1- or BRCA2-associated hereditary breast carcinoma in Japanese women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Breast cancer survival in BRCA1 carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Breast cancer incidence, penetrance and survival in probable carriers of BRCA1 gene mutation in families linked to BRCA1 on chromosome 17q12-21

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Prognosis of BRCA1 hereditary breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

p53 protein expression in human breast carcinoma: relationship to expression of epidermal growth factor receptor, c-erbB-2 protein overexpression, and oestrogen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Breast carcinomas arising in carriers of mutations in BRCA1 or BRCA2: are they prognostically different?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

The influence of familial and hereditary factors on the prognosis of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Survival of patients with breast cancer and BRCA1 mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Primary node negative breast cancer in BRCA1 mutation carriers has a poor outcome.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Survival in early-onset BRCA1 breast-cancer patients. Institut Curie Breast Cancer Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

BRCA-associated breast cancer in young women

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Breast and other cancers in families with ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Breast cancer and other cancers in Norwegian families with ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Cancer risks in A-T heterozygotes

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

The inherited component of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Genetic Haplotyping of Ataxia-telangiectasia Families Localizes the Major Gene to an ∼ 850 kb Region on Chromosome 11q23.1.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

A single ataxia telangiectasia gene with a product similar to PI-3 kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

ATM mutations and phenotypes in ataxia-telangiectasia families in the British Isles: expression of mutant ATM and the risk of leukemia, lymphoma, and breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: haplotype study in French AT families

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Heterozygous ATM mutations do not contribute to early onset of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Ataxia-telangiectasia, cancer and the pathobiology of the ATM gene

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

ATM-heterozygous germline mutations contribute to breast cancer-susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

1 reference

7 January 2021

Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Cowden's disease. A possible new symptom complex with multiple system involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Multiple Hamartoma Syndrome (Cowden's Disease)

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Cowden's disease (multiple hamartoma and neoplasia syndrome). A case report and review of the English literature

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Cowden's disease: a cutaneous marker of breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Analysis of the 10q23 chromosomal region and the PTEN gene in human sporadic breast carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

Novel germline mutations in the PTEN tumour suppressor gene found in women with multiple cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0959-8049%2800%2900378-6

1 reference

7 January 2021

10.1016/S0959-8049(00)00378-6

Identifiers

DOI

1 reference

31 July 2017

1 reference

PubMed ID

11239752